Coherus BioSciences, Inc. has several approved biosimilars such as UDENYCA, CIMERLI and YUSIMRY. Full-year 2023 net product sales of biosimilars expected to exceed $275 million. Immuno-oncology ...
Adamis Pharmaceuticals Corp ADMP announced its NDA filing Friday for a fast-dissolving sublingual tadalafil tablet for erectile dysfunction. The submission of the NDA is positive, as an approval would ...
DUBLIN--(BUSINESS WIRE)--The "Enterprise Pipeline Management Solutions - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering. According to the report, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback